ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
2,830,358
Share change
+309,534
Total reported value
$5,745,277
Put/Call ratio
0%
Price per share
$2.03
Number of holders
22
Value change
+$631,266
Number of buys
4
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q2 2023

As of 30 Jun 2023, ARCA BIOPHARMA INC - COM (ABIO) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,830,358 shares. The largest 10 holders included BML Capital Management, LLC, Western Standard LLC, VANGUARD GROUP INC, Newtyn Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Murchinson Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.